Sabrina Wildner's and Gabirele Gadermaier's study into aptamer selection of interaction with therapeutic proteins entitled Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab has been accepted by Scientific Reports. Preprint will follow soon. Very pleasing!
For the 14th time, researchers and stakeholders of the Christian Doppler Laboratory met to exchange progress made and discuss new ideas. Thanks to Rowan Moore and Frank Steiner for hosting this meeting at the Thermo Fisher Scientific site in Germering!